QQ客服 官方微博 反馈留言

	Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST) A case report
	Ding, Xingchen; Wang, Linlin; Liu, Xijun; Sun, Xindong; Yu, Jinming; Meng, Xue
刊名	MEDICINE
	2017
卷号	96期号:10
关键词	early-stage NSCLC EGFR-TKI genetic examination metachronous second primary tumor therapy
DOI	10.1097/MD.0000000000006221
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4585846
专题	山东大学
作者单位	1.Weifang Med Univ, Dept Oncol, Weifang, Peoples R China. 2.[Ding, Xingchen 3.Wang, Linlin 4.Liu, Xijun 5.Sun, Xindong 6.Yu, Jinming 7.Meng
推荐引用方式 GB/T 7714	Ding, Xingchen,Wang, Linlin,Liu, Xijun,et al. Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST) A case report[J]. MEDICINE,2017,96(10).
APA	Ding, Xingchen,Wang, Linlin,Liu, Xijun,Sun, Xindong,Yu, Jinming,&Meng, Xue.(2017).Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST) A case report.MEDICINE,96(10).
MLA	Ding, Xingchen,et al."Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST) A case report".MEDICINE 96.10(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。